ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1531	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
385	Anyone care to guess a target price in the next week for this stock? The short i	zagnut1	-	4/23/2024
384	I want to thank everyone on this thread for sharing this fantastic due diligence	timi2004	-	4/23/2024
383	Duration of Complete Response now 47 months and counting. Wowzers.	ghettogoulash	-	4/22/2024
382	Pr is out finance.yahoo.com	mannamal	1	4/22/2024
381	I was thinking the same: partnership possibly announced tomorrow.	ghettogoulash	-	4/22/2024
380	Big surprise! Any idea how much this expands the addressable market?	ghettogoulash	-	4/22/2024
379	Congrats Hat!!!! You have been one of the primary of new and quality diligence	Davidoff	4	4/22/2024
378	FDA Calendar Company Name ImmunityBio, Inc IBRX Drug Name N-803 (Resubmitt	Davidoff	-	4/22/2024
377	From my reading of the link below, it appears it is approved. Any other confirm	Davidoff	-	4/22/2024
376	Okay folks, this is why you read this board: approved label is both with and wit	TinfoilHat	6	4/22/2024
375	fda.gov	urslor	2	4/22/2024
374	look at fda website. ?approved	urslor	-	4/22/2024
373	A few thoughts on the Anktiva PDUFA tomorrow which now is a cliff hanger. Effica	End2War	-	4/22/2024
372	As ImmunityBio (IBRX) edges closer to potentially receiving FDA approval for Ank	End2War	4	4/20/2024
371	Business as usual... Until it's not. (eom)	JJINV	-	4/18/2024
370	It suggests to me that they have not received an answer from the FDA and they ar	End2War	1	4/18/2024
369	Hope so. Did you see the Mixed Shelf Offering filed by IBRX after the close tod	Davidoff	1	4/17/2024
368	My official guess is that MRK will do a deal with IBRX because of its patent cli	End2War	2	4/17/2024
367	Yes, I agree it does seem odd, and an inspection of the IBRX web page does not r	End2War	2	4/16/2024
366	$31 / hr? That is an oddly low salary. If commissions are paid you would think	TripleE3	-	4/16/2024
365	stocktwits.com	End2War	-	4/16/2024
364	By the way, cannot remember if I read this on this board or on yahoo, but there	TinfoilHat	-	4/15/2024
363	Hope we are both on the right side of history and the FDA decision... Think yo	Davidoff	-	4/15/2024
362	I'm also interested in these lending rates, my assumption is the trading pla	TinfoilHat	6	4/15/2024
361	Vanguard Group Inc. grew its position in shares of ImmunityBio, Inc. ( NASDAQ:IB	zagnut1	4	4/14/2024

Go to reply# or date (mm/dd/yy):